On the other hand, among the therapies evaluated to a lesser extent, only topiroxostat showed a highly significant hypouricemic effect. 3.2.2 Nephroprotective effect Most of the included trials evaluated the nephroprotective effect through the eGFR.
← all excerpts
Effect of uric acid reduction on chronic kidney disease. Systematic review and meta-analysis.
1
—
—